Skip to main content
Log in

A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Psychotomimetic N-methyl-d-aspartate/glutamate receptor antagonists, such as phencyclidine (PCP), have been shown to produce a spectrum of behavioral, neurochemical and anatomical changes in rats that are relevant to aspects of schizophrenia, including impairments of working memory and visual attention. The alpha2 noradrenergic receptor agonist clonidine prevents some of the behavioral effects of NMDA antagonists, suggesting that monoaminergic systems mediate some aspects of these deficits.

Objectives

We sought to determine the ability of clonidine to modify the PCP-induced deficits of visual attention and spatial working memory in rats.

Results

In a lateralized reaction time task, a lower dose of clonidine (10 μg/kg) ameliorated the impairment of choice accuracy produced by PCP (2.5 mg/kg, IP), while the higher dose of clonidine (50 μg/kg) slowed response times and induced a deficit of choice accuracy on its own. The high dose of clonidine effectively prevented the motor impulsivity produced by PCP. In addition, clonidine (10 μg/kg) prevented PCP-induced performance deficits in a delayed non-match to sample task.

Conclusions

These data indicate that clonidine may attenuate deficits of attention and working memory produced by PCP, perhaps in part by preventing some of the downstream neurochemical and anatomical effects of this psychotomimetic drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Andrews GD, Nogueira L, Lavin A (2003) Characterization of noradrenergic effects on pyramidal neurons: In vivo and in vitro studies. Society for Neuroscience, p 461.4

    Google Scholar 

  • Aoki C, Venkatesan C, Go CG, Forman R, Kurose H (1998) Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. Cereb Cortex 8:269–277

    Article  CAS  PubMed  Google Scholar 

  • Arnsten AF, Goldman-Rakic PS (1985) Alpha2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 230:1273–1276

    CAS  PubMed  Google Scholar 

  • Brozoski TJ, Brown RM, Rosvold HE, Goldman PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929–932

    CAS  PubMed  Google Scholar 

  • Bushnell PJ, Oshiro WM, Padnos BK (1997) Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention. Psychopharmacology 134:230–241

    Article  CAS  PubMed  Google Scholar 

  • Carli M, Evenden JL, Robbins TW (1985) Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention. Nature 313:679–682

    CAS  PubMed  Google Scholar 

  • Chergui K, Akaoka H, Brunet JL, Charlety PJ, Saunier CF, Buda M, Privat A, Vignon J, Kamenka JM, Chouvet G (1992) Inhibition of locus coeruleus neurons by the phencyclidine analog, N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine: evidence for potent indirect adrenoceptor agonist properties. Eur J Pharmacol 219:169–172

    Article  CAS  PubMed  Google Scholar 

  • Coan EJ, Collingridge GL (1987) Effects of phencyclidine, SKF 10,047 and related psychotomimetic agents on N-methyl-d-aspartate receptor mediated synaptic responses in rat hippocampal slices. Br J Pharmacol 91:547–556

    CAS  PubMed  Google Scholar 

  • Coull JT (1994) Pharmacological manipulations of the alpha2-noradrenergic system. Effects on cognition. Drugs Aging 5:116–126

    CAS  PubMed  Google Scholar 

  • Deutch AY, Tam SY, Freeman AS, Bowers MB, Jr., Roth RH (1987) Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. Eur J Pharmacol 134:257–264

    Article  CAS  PubMed  Google Scholar 

  • Duncan EJ, Madonick SH, Parwani A, Angrist B, Rajan R, Chakravorty S, Efferen TR, Szilagyi S, Stephanides M, Chappell PB, Gonzenbach S, Ko GN, Rotrosen JP (2001) Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology 25:72–83

    CAS  PubMed  Google Scholar 

  • Farber NB, Foster J, Duhan NL, Olney JW (1995) Alpha2 adrenergic agonists prevent MK-801 neurotoxicity. Neuropsychopharmacology 12:347–349

    CAS  PubMed  Google Scholar 

  • Fields RB, Van Kammen DP, Peters JL, Rosen J, Van Kammen WB, Nugent A, Stipetic M, Linnoila M (1988) Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings. Schizophr Res 1:417–423

    Article  CAS  PubMed  Google Scholar 

  • Friedman JI, Adler DN, Temporini HD, Kemether E, Harvey PD, White L, Parrella M, Davis KL (2001) Guanfacine treatment of cognitive impairment in schizophrenia. Neuropsychopharmacology 25:402–409

    Article  CAS  PubMed  Google Scholar 

  • Greene R (2001) Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia. Hippocampus 11:569–577

    Article  CAS  PubMed  Google Scholar 

  • Gresch PJ, Sved AF, Zigmond MJ, Finlay JM (1995) Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 65:111–116

    CAS  PubMed  Google Scholar 

  • Grottick AJ, Higgins GA (2000) Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res 117:197–208

    CAS  PubMed  Google Scholar 

  • Guillermain Y, Micallef J, Possamai C, Blin O, Hasbroucq T (2001) N-Methyl-d-aspartate receptors and information processing: human choice reaction time under a subanaesthetic dose of ketamine. Neurosci Lett 303:29–32

    Article  CAS  PubMed  Google Scholar 

  • Gutnikov SA, Barnes JC, Rawlins JN (1994) Working memory tasks in five-choice operant chambers: use of relative and absolute spatial memories. Behav Neurosci 108:899–910

    Article  CAS  PubMed  Google Scholar 

  • Harkin A, Morris K, Kelly JP, O’Donnell JM, Leonard BE (2001) Modulation of MK-801-induced behaviour by noradrenergic agents in mice. Psychopharmacology 154:177–188

    Google Scholar 

  • Hertel P, Nomikos GG, Schilstrom B, Arborelius L, Svensson TH (1997) Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha2-adrenoceptor antagonism. Neuropsychopharmacology 17:44–55

    CAS  PubMed  Google Scholar 

  • Jakala P, Riekkinen M, Sirvio J, Koivisto E, Riekkinen P, Jr. (1999) Clonidine, but not guanfacine, impairs choice reaction time performance in young healthy volunteers. Neuropsychopharmacology 21:495–502

    Article  CAS  PubMed  Google Scholar 

  • Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301–1308

    CAS  PubMed  Google Scholar 

  • Jentsch JD (2003) Genetic vasopressin deficiency facilitates performance of a lateralized reaction time task: altered attention and motor processes. J Neurosci 23:1066–1071

    CAS  PubMed  Google Scholar 

  • Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201–225

    CAS  PubMed  Google Scholar 

  • Jentsch JD, Taylor JR (2003) Sex differences in visuospatial divided attention and motor impulsivity in rats. Behav Neurosci 117:76–83

    Article  PubMed  Google Scholar 

  • Jentsch JD, Wise A, Katz Z, Roth RH (1998) Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex. Synapse 28:21–26

    Article  CAS  PubMed  Google Scholar 

  • Jin J, Yamamoto T, Watanabe S (1997) The involvement of sigma receptors in the choice reaction performance deficits induced by phencyclidine. Eur J Pharmacol 319:147–152

    Article  CAS  PubMed  Google Scholar 

  • Kim SH, Price MT, Olney JW, Farber NB (1999) Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists. Mol Psychiatry 4:344–352

    CAS  PubMed  Google Scholar 

  • Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199–214

    CAS  PubMed  Google Scholar 

  • Krystal JH, Anand A, Moghaddam B (2002) Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry 59:663–664

    Article  PubMed  Google Scholar 

  • Kubota T, Hirota K, Yoshida H, Takahashi S, Anzawa N, Ohkawa H, Kushikata T, Matsuki A (1999a) Effects of sedatives on noradrenaline release from the medial prefrontal cortex in rats. Psychopharmacology 146:335–338

    Article  CAS  PubMed  Google Scholar 

  • Kubota T, Hirota K, Yoshida H, Takahashi S, Ohkawa H, Anzawa N, Kushikata T, Matsuki A (1999b) Inhibitory effect of clonidine on ketamine-induced norepinephrine release from the medial prefrontal cortex in rats. Br J Anaesth 83:945–947

    CAS  PubMed  Google Scholar 

  • Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14:301–307

    CAS  PubMed  Google Scholar 

  • McCann DJ, Rabin RA, Winter JC (1987) Interactions of clonidine with phencyclidine and ketamine: studies of radial maze performance and righting reflex in rats. Pharmacol Biochem Behav 26:23–28

    Article  CAS  PubMed  Google Scholar 

  • Moghaddam B, Adams BW (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349–1352

    CAS  PubMed  Google Scholar 

  • Murase S, Nisell M, Grenhoff J, Svensson TH (1992) Decreased sensory responsiveness of noradrenergic neurons in the rat locus coeruleus following phencyclidine or dizocilpine (MK-801): role of NMDA antagonism. Psychopharmacology 109:271–276

    CAS  PubMed  Google Scholar 

  • Newcomer JW, Krystal JH (2001) NMDA receptor regulation of memory and behavior in humans. Hippocampus 11:529–542

    Article  CAS  PubMed  Google Scholar 

  • Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, Craft S, Olney JW (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20:106–118

    CAS  PubMed  Google Scholar 

  • Olney JW, Newcomer JW, Farber NB (1999) NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33:523–533

    CAS  PubMed  Google Scholar 

  • Oranje B, van Berckel BN, Kemner C, van Ree JM, Kahn RS, Verbaten MN (2000) The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology 22:293–302

    CAS  PubMed  Google Scholar 

  • Presburger G, Robinson JK (1999) Spatial signal detection in rats is differentially disrupted by delta-9-tetrahydrocannabinol, scopolamine, and MK-801. Behav Brain Res 99:27–34

    Article  CAS  PubMed  Google Scholar 

  • Sams-Dodd F (1999) Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Rev Neurosci 10:59–90

    CAS  PubMed  Google Scholar 

  • Stefani MR, Moghaddam B (2002) Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat. Behav Brain Res 134:267–274

    Article  CAS  PubMed  Google Scholar 

  • Tamminga CA (1998) Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12:21–36

    CAS  PubMed  Google Scholar 

  • Tang AH, Franklin SR (1983) Disruption of brightness discrimination in a shock avoidance task by phencyclidine and its antagonism in rats. J Pharmacol Exp Ther 225:503–508

    CAS  PubMed  Google Scholar 

  • Terry AV Jr, Risbrough VB, Buccafusco JJ, Menzaghi F (2002) Effects of (±)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys. J Pharmacol Exp Ther 301:284–292

    Google Scholar 

  • Tsai G, Coyle JT (2002) Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 42:165–179

    Article  CAS  PubMed  Google Scholar 

  • Varvel SA, Hamm RJ, Martin BR, Lichtman AH (2001) Differential effects of delta 9-THC on spatial reference and working memory in mice. Psychopharmacology 157:142–150

    Google Scholar 

  • Witte EA, Marrocco RT (1997) Alteration of brain noradrenergic activity in rhesus monkeys affects the alerting component of covert orienting. Psychopharmacology 132:315–323

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. David Jentsch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jentsch, J.D., Anzivino, L.A. A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats. Psychopharmacology 175, 76–83 (2004). https://doi.org/10.1007/s00213-004-1772-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-004-1772-3

Keywords

Navigation